ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney transplantation"

  • 2021 American Transplant Congress

    Urinary Exosomal Cystatin C and Lipopolysaccharide Binding Protein as Biomarkers for Monitoring Antibody-mediated Rejection After Kidney Transplantation

    M. Kim, S. Lim, S. Shin

    Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of

    *Purpose: This study aims to discover and validate urinary exosomal biomarkers for antibody-mediated rejection (ABMR) after kidney transplantation.*Methods: A total of 60 urine samples from…
  • 2021 American Transplant Congress

    Single Center Experience Comparing Two Clinically Available Donor Derived Cell Free DNA Tests

    S. Bunnapradist1, S. Lee2, P. Homkrailas3, G. Danovitch3

    1UCLA, Los Angeles, CA, 2Pharmacy, David Geffen School of Medicine at UCLA, Los Angeles, CA, 3David Geffen School of Medicine at UCLA, Los Angeles, CA

    *Purpose: Donor derived cell-free DNA (dd cf-DNA), this new technology allows for non-invasive monitoring of graft function. Two most commonly used assays are Prospera (Natera®,…
  • 2021 American Transplant Congress

    Role of Trugraf Testing in Kidney Allografts Previously Biopsied for Dysfunction

    Y. A. Qazi1, W. Mon1, C. Choi1, S. Qazi2, M. Smogorzewski1

    1Keck Medical Center at USC, Los Angeles, CA, 2Keck Medical Center at USC, La Canada Flt, CA

    *Purpose: TruGraf®, can be used as an alternative to surveillance biopsies for ruling out “silent” subclinical acute rejections in transplant patients with stable graft function.…
  • 2021 American Transplant Congress

    A Payer’s Perspective: The Cost of Hemodialysis versus Living Donor Kidney Transplant for Kidney Failure Patients in Nigeria

    J. Lang1, I. James2, D. Da Rocha Afodu1, C. G. Okwuonu3, O. Ekwenna1

    1University of Toledo College of Medicine and Life Sciences, Toledo, OH, 2Surgical Specialists of Charlotte, Matthews, NC, 3Department of Internal Medicine, Nephrology Unit, Federal Medical Centre, Umuahia, Abia State, Nigeria

    *Purpose: To primarily quantify the costs of LDKT and HD in Nigeria from a ‘payer’s perspective’ and secondarily inform future cost-effectiveness studies to guide health…
  • 2021 American Transplant Congress

    Kidney Transplant Outcomes in HIV+ Recipients: A Single-Center Study

    M. Samra1, A. Hall2, I. Tang2

    1Medicine, Edward Hines VA, Hines, IL, 2Medicine, University of Illinois, Chicago, IL

    *Purpose: HIV+ patients are eligible to recieve a kidney transplant (KT) provided they meet criteria of undetectable viral load (VL) and CD4 count >200. We…
  • 2021 American Transplant Congress

    Impact of Belatacept and Tacrolimus on Cmv Viral Load Control and Relapse in Moderate and High-risk Cmv Serostatus Kidney Transplant Recipients

    W. Magua1, A. C. Johnson1, G. M. Karadkhele1, I. R. Badell1, P. Vasanth1, M. G. Lyon III2, A. K. Mehta2, K. A. Easley3, J. Rickert4, C. P. Larsen1

    1Department of Surgery, Emory University, Atlanta, GA, 2Department of Medicine, Emory University, Atlanta, GA, 3Biostatistics and Bioinformatics, Emory University, Atlanta, GA, 4RStudio and R Consortium, San Jose, CA

    *Purpose: We aim to evaluate the impact of belatacept and tacrolimus on CMV viral load control, remission and relapse in CMV high-risk (serostatus, D+/R-) and…
  • 2021 American Transplant Congress

    Hepatitis E Diagnosis and Management After Liver, Kidney, or Heart Transplant: A Single Center Experience

    M. Carter1, M. Fitzmaurice2, S. Yeddula2, A. Singh2, S. Nagai2, S. Jafri2

    1Wayne State University School of Medicine, Detroit, MI, 2Henry Ford Health System, Detroit, MI

    *Purpose: Transplant-related Hepatitis E virus (HEV) infection is a rarely recognized entity with significant clinical importance given potential for chronic hepatitis post-transplant. We evaluated HEV…
  • 2021 American Transplant Congress

    Findings from the BARETO Study: A New, Composite Renal Vascular Plaque Score is Highly Associated with Kidney Graft Survival

    J. Foutz1, D. Stewart1, L. Kamal2, H. McGehee1, P. Saravanane2, S. Yu2, R. Yousfi2, G. Gupta2

    1United Network for Organ Sharing, Richmond, VA, 2Virginia Commonwealth University School of Medicine, Richmond, VA

    *Purpose: Whether anatomic findings such as aortic and arterial renal plaque affect kidney graft outcomes is not well defined. Other than anatomical damage, it is…
  • 2021 American Transplant Congress

    Can Procurement Biopsy Data Tell Us Anything? The Influence of Interstitial Fibrosis on Long-term Kidney Graft Survival

    D. Stewart1, J. Foutz1, L. Kamal2, H. McGehee1, P. Saravanane2, S. Yu3, R. Yousfi2, G. Gupta2

    1Research, United Network for Organ Sharing, Richmond, VA, 2Virginia Commonwealth University Health, Richmond, VA, 3Research, Virginia Commonwealth University Health, Richmond, VA

    *Purpose: Biopsy findings have been shown to have a profound impact on kidney utilization decisions. Most studies of the association between procurement biopsy findings and…
  • 2021 American Transplant Congress

    How Should Acute T-Cell Mediated Rejection of Kidney Transplants be Treated?

    F. Aziz1, S. Parajuli2, N. Garg2, M. Mohamed2, A. Djamali2, D. Mandelbrot2

    1University of Wisconsin, Madison, WI, 2University of Wisconsin, Verona, WI

    *Purpose: Many guidelines suggest treating acute T-cell mediated rejection (TCMR) of kidney allografts that is Banff grade I with steroids alone and Banff grade II…
  • « Previous Page
  • 1
  • …
  • 95
  • 96
  • 97
  • 98
  • 99
  • …
  • 531
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences